“Low-intensity extracorporeal shock wave therapy in vasculogenic erectile dysfunction refractory to PDE5 inhibitors: a prospective study with 12- and 18-month outcomes”, Arch Ital Urol Androl, vol. 98, no. 1, Mar. 2026, doi: 10.4081/aiua.2026.14707.